PCNA Inhibitor Exploits Cancer-Selective Vulnerability to Suppress Tumor Growth

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(11): 1152
DOI: 10.1055/s-0042-1752290

Innovative Drug Discovery and Development

Contributor(s):

Dirk Trauner

,

Joseph A. Flores

PCNA - transcription-replication conflict (TRC) - DNA replication stress - DNA repair - structure-activity relationship (SAR)

Article published online:
14 October 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany